Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Anna, Kuisma"'
Autor:
Anna Kuisma, Iiro Ranta, Jani Keyriläinen, Sami Suilamo, Pauliina Wright, Marko Pesola, Lizette Warner, Eliisa Löyttyniemi, Heikki Minn
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 13, Iss , Pp 14-20 (2020)
Background and purpose: Magnetic resonance imaging (MRI) is increasingly used in radiation therapy planning of prostate cancer (PC) to reduce target volume delineation uncertainty. This study aimed to assess and validate the performance of a fully au
Externí odkaz:
https://doaj.org/article/7879d0444cc244e8b4519452fe4788e5
Autor:
Irena Saarinen, Ivan Jambor, Mai Kim, Anna Kuisma, Jukka Kemppainen, Harri Merisaari, Olli Eskola, Anna-Riina Koskenniemi, Ileana Montoya Perez, Peter Boström, Pekka Taimen, Heikki Minn
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-11 (2019)
Abstract Purpose To evaluate the expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter1 (LAT1) in prostate cancer (PCa) and their impact on uptake of 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluci
Externí odkaz:
https://doaj.org/article/4a5d4265f2ad44a5a2c9d1232ef567d9
Autor:
Samuli Arvola, Ivan Jambor, Anna Kuisma, Jukka Kemppainen, Sami Kajander, Marko Seppänen, Tommi Noponen
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-9 (2019)
Abstract Background Despite recent technological advances allowing for quantitative single-photon emission computed tomography (SPECT), quantitative SPECT has not been widely used in the clinical practice. The aim of this study is to evaluate the fea
Externí odkaz:
https://doaj.org/article/ed37784dda8c4d6bb98fbcbec9d39d7e
Autor:
Mari Koivisto, Paula Lindholm, Sami Suilamo, Heikki Minn, Pauliina Wright, Jan Seppälä, Anna Kuisma
Publikováno v:
Acta Oncologica. 61:97-103
Biologically created subvolumes enable non-uniform dose distributions in prostate cancer radiotherapy (RT) thus potentially improving therapeutic ratio and reducing toxicity. We present the long-term outcome of men receiving focal boosting of carbon-
Autor:
Anna Kuisma, Simona Malaspina, Mika Scheinin, Ernst J. Postema, Kalle Mattila, Kari K. Kalliokoski, Peter J. Boström, Otto Ettala, Matthew P. Miller, Heikki Minn, Vesa Oikonen
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose This phase 1 open-label study evaluated the uptake kinetics of a novel theranostic PET radiopharmaceutical, 18F-rhPSMA-7.3, to optimise its use for imaging of prostate cancer. Methods Nine men, three with high-risk localised prostate cancer,
Autor:
Samuli Arvola, Marko Seppänen, Simona Malaspina, Sorjo Mätzke, Juho Raiko, Kirsi L. Timonen, Otto Ettala, Ivan Jambor, Mikael Anttinen, Anna Kuisma, Eliisa Löyttyniemi, Peter J. Boström, Antti Sohlberg, Tommi Noponen
Objective The aim of this study was to compare reprojected bone SPECT/CT (RBS) against planar bone scintigraphy (BS) in the detection of bone metastases in breast and prostate cancer patients. Methods Twenty-six breast and 105 prostate cancer patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55c29e66670f9afb4ade498c973fb1c1
http://hdl.handle.net/10138/344265
http://hdl.handle.net/10138/344265
Autor:
Simona Malaspina, Matthew P. Miller, Salla Lahdenpohja, Kari K. Kalliokoski, Anna Kuisma, Tuula Tolvanen, Mika Scheinin, Ernst J. Postema
Publikováno v:
Journal of Nuclear Medicine. 62:679-684
This first-in-human study investigated the safety, biodistribution and radiation dosimetry of the novel 18F-labeled radiohybrid prostate-specific membrane antigen (rhPSMA) positron emission tomography (PET) imaging agent, 18F-rhPSMA-7.3. Methods: Six
Autor:
Ivan Jambor, Parisa Movahedi, Ileana Montoya Perez, Olli Eskola, Anna Kuisma, M. Pesola, Tapio Pahikkala, Heikki Minn, Hannu J. Aronen, Pekka Taimen, Peter J. Boström, Jukka Kemppainen, Otto Ettala, Esa Kähkönen, Timo Liimatainen, Harri Merisaari, Jarmo Teuho, Jani Saunavaara
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
The aim of this prospective single-institution clinical trial (NCT02002455) was to evaluate the potential of advanced post-processing methods for 18F-Fluciclovine PET and multisequence multiparametric MRI in the prediction of prostate cancer (PCa) ag
Autor:
Simona, Malaspina, Pekka, Taimen, Markku, Kallajoki, Vesa, Oikonen, Anna, Kuisma, Otto, Ettala, Kalle, Mattila, Peter J, Boström, Heikki, Minn, Kari, Kalliokoski, Ernst J, Postema, Matthew P, Miller, Mika, Scheinin
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 37(3)
Autor:
Heikki Minn, Pauliina Wright, Jani Keyriläinen, Iiro Ranta, Anna Kuisma, Eliisa Löyttyniemi, Sami Suilamo, Lizette Warner, Marko Pesola
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 13, Iss, Pp 14-20 (2020)
Physics and Imaging in Radiation Oncology
Physics and Imaging in Radiation Oncology
Background and purpose: Magnetic resonance imaging (MRI) is increasingly used in radiation therapy planning of prostate cancer (PC) to reduce target volume delineation uncertainty. This study aimed to assess and validate the performance of a fully au